Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Vascular Surgery

• Publication date

  2001-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1067/MVA.2001.112810PMID 11331849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

  2000cited by this paper
• Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.

  2000cited by this paper
• Angiotensin II receptor antagonists.

  2000cited by this paper
• Cardiac protection: evolving role of angiotensin receptor blockers.

  2000cited by this paper
• Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms.

  2000cited by this paper
• Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system.

  2000cited by this paper
• Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts.

  2000cited by this paper
• Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms.

  2000cited by this paper
• Inhibition of gelatinase A (MMP‐2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma

  1999cited by this paper
• Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes.

  1999cited by this paper
• Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms.

  1999cited by this paper
• "Variable induction of experimental abdominal aortic aneurysms with different preparations of porcine pancreatic elastase".

  1999cited by this paper
• Cystatin C deficiency in human atherosclerosis and aortic aneurysms.

  1999cited by this paper
• The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms.

  1999cited by this paper
• Enalapril improves arterial elastic properties in rats with myocardial infarction.

  1999cited by this paper
• Angiotensin induces inflammatory activation of human vascular smooth muscle cells.

  1999cited by this paper
• Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry.

  1999cited by this paper
• Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase.

  1999cited by this paper
• MMP Inhibition in Abdominal Aortic Aneurysms: Rationale for a Prospective Randomized Clinical Trial

  1999cited by this paper
• Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908).

  1999cited by this paper
• Cathepsin D and Cathepsin L Activities in Aortic Aneurysm Wall and Parietal Thrombus

  1998cited by this paper
• Angiotensin-Converting Enzyme Inhibition Alters Clusterin mRNA Expression in the Kidney following Renal Mass Reduction

  1998cited by this paper
• Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines.

  1998cited by this paper
• Vascular remodeling: the role of angiotensin-converting enzyme inhibitors.

  1998cited by this paper
• Angiotensin-converting enzyme inhibitors.

  1998cited by this paper
• Salt-sensitive aortic aneurysm and rupture in hypertensive transgenic mice that overproduce angiotensin II.

  1998cited by this paper
• The potential role of angiotensin II in the vasculature

  1998cited by this paper
• Salt-sensitive hypertension induced by sensory denervation: introduction of a new model.

  1998cited by this paper
• Therapeutic Potential of Tetracycline Derivatives to Suppress the Growth of Abdominal Aortic Aneurysms

  1998cited by this paper
• Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells.

  1998cited by this paper
• Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects.

  1997cited by this paper
• Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis.

  1997cited by this paper
• Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

  1997cited by this paper
• Pressure-independent effects of AT1-receptor antagonism on cardiovascular remodeling in aortic-banded rats.

  1997cited by this paper
• Anti-CD 18 monoclonal antibody slows experimental aortic aneurysm expansion.

  1996cited by this paper
• Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.

  1996cited by this paper
• Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase.

  1996cited by this paper
• Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat.

  1996cited by this paper
• Inflammatory aspects of experimental aneurysms. Effect of methylprednisolone and cyclosporine.

  1996cited by this paper
• Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease.

  1996cited by this paper
• Angiotensin II increases monocyte binding to endothelial cells.

  1996cited by this paper
• Inflammatory Aspects of Experimental Aneurysms

  1996cited by this paper
• Role of Matrix Metalloproteinases in Abdominal Aortic Aneurysms a

  1996cited by this paper
• Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.

  1996cited by this paper
• Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem.

  1996cited by this paper
• Contribution of systemic blood pressure to myocardial remodeling in uremic rats.

  1995cited by this paper
• Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.

  1995cited by this paper
• Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV.

  1995cited by this paper
• The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

  1995cited by this paper
• Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.

  1995cited by this paper
• Vascular and myocardial protective effects of converting enzyme inhibition in experimental heart failure.

  1995cited by this paper
• Activation of human peripheral monocytes by angiotensin II

  1994cited by this paper
• Potential Importance of Tissue Angiotensin‐Converting Enzyme Inhibition in Preventing Neointima Formation

  1994cited by this paper
• Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease.

  1994cited by this paper
• Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis.

  1994cited by this paper
• Failure of Elastin or Collagen as Possible Critical Connective Tissue Alterations Underlying Aneurysmal Dilatation

  1994cited by this paper
• The elastase infusion model of experimental aortic aneurysms: synchrony of induction of endogenous proteinases with matrix destruction and inflammatory cell response.

  1994cited by this paper
• Expansion of aortic aneurysms is reduced by propranolol in a hypertensive rat model.

  1994cited by this paper
• Stimulation of Plasminogen Activator Inhibitor In Vivo by Infusion of Angiotensin II Evidence of a Potential Interaction Between the Renin‐Angiotensin System and Fibrinolytic Function

  1993cited by this paper
• Identification of a fourth angiotensin AT1 receptor subtype in rat.

  1993cited by this paper
• Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

  1993cited by this paper
• Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases.

  1993cited by this paper
• Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms.

  1992cited by this paper
• Molecular Mechanisms of Vascular Renin‐Angiotensin System in Myointimal Hyperplasia

  1991cited by this paper
• Angiotensin II induces secretion of plasminogen activator inhibitor 1 and a tissue metalloprotease inhibitor-related protein from rat brain astrocytes.

  1991cited by this paper
• Surgery of the Aorta and Its Branches

  1970cited by this paper

• Sex-based differences in cardiovascular risk management and abdominal aortic aneurysm growth: Insights from a contemporary cohort study.

  2026cites this paper
• Therapeutic Strategies for Abdominal Aortic Aneurysm: A Comprehensive Systematic Review

  2025cites this paper
• A Multifaceted Approach to Abdominal Aortic Aneurysm

  2025cites this paper
• Calcium channel blockers increase the risk of aortic aneurysm and dissection

  2025cites this paper
• Mendelian randomization did not support the causal effect of diabetes on aortic diseases

  2024cites this paper
• Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases.

  2023cites this paper
• Alkaline ceramidase 1–mediated platelet ceramide catabolism mitigates vascular inflammation and abdominal aortic aneurysm formation

  2023cites this paper
• Increased plasma renin by vasodilators promotes the progression of abdominal aortic aneurysm

  2023cites this paper
• Silicate ions as soluble form of bioactive ceramics alleviate aortic aneurysm and dissection.

  2022cites this paper
• Research advances in drug therapy for abdominal aortic aneurysms over the past five years: An updated narrative review.

  2022cites this paper
• Carbon monoxide releasing molecule-2 attenuates angiotensin II-induced IL-6/Jak2/Stat3-associated inflammation by inhibiting NADPH oxidase- and mitochondria-derived ROS in human aortic smooth muscle cells.

  2022cites this paper
• Pharmacotherapy in Clinical Trials for Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis

  2022cites this paper
• Temporal and Quantitative Analysis of Aortic Immunopathologies in Elastase-Induced Mouse Abdominal Aortic Aneurysms

  2021cites this paper
• Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms

  2021cites this paper
• DRD4 (Dopamine D4 Receptor) Mitigate Abdominal Aortic Aneurysm via Decreasing P38 MAPK (mitogen-activated protein kinase)/NOX4 (NADPH Oxidase 4) Axis–Associated Oxidative Stress

  2021cites this paper
• Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways.

  2020cites this paper
• MiR-144-5p limits experimental abdominal aortic aneurysm formation by mitigating M1 macrophage-associated inflammation: Suppression of TLR2 and OLR1.

  2020cites this paper
• Angiotensin I Infusion Reveals Differential Effects of Angiotensin-Converting Enzyme in Aortic Resident Cells on Aneurysm Formation.

  2020cites this paper
• Contemporary Outcomes of Endovascular Abdominal Aortic Aneurysm Repair in Patients Deemed Unfit for Open Surgical Repair.

  2020cites this paper
• Captopril versus atenolol to prevent expansion rate of thoracic aortic aneurysms: rationale and design.

  2020cites this paper
• ATRQβ‐001 Vaccine Prevents Experimental Abdominal Aortic Aneurysms

  2019cites this paper
• Comprehensive Cardiac Rehabilitation as a Therapeutic Strategy for Abdominal Aortic Aneurysm

  2019cites this paper
• Cellular Mechanisms of Aortic Aneurysm Formation.

  2019cites this paper
• Pharmacologic Management of Aneurysms.

  2019cites this paper
• Possible Effect of Alcohol Consumption on Aortic Dilatation by Inducing Renin–Angiotensin–Aldosterone System

  2019cites this paper
• Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.

  2018cites this paper
• Diabetes mellitus as a protective factor of abdominal aortic aneurysm: Possible mechanisms.

  2018cites this paper
• The oral administration of clarithromycin prevents the progression and rupture of aortic aneurysm

  2018cites this paper
• Diabetes mellitus as a protective factor of abdominal aortic aneurysm: Possible mechanisms

  2018cites this paper
• A Targeting Nanotherapy for Abdominal Aortic Aneurysms.

  2018cites this paper
• Comparison of Efficacy between Ramipril and Carvedilol on Limiting the Expansion of Abdominal Aortic Aneurysm in Mouse Model

  2018cites this paper
• ROLE OF SEX CHROMOSOMES IN SEXUAL DIMORPHISM OF ANGII-INDUCED ABDOMINAL AORTIC ANEURYSMS

  2018cites this paper
• The binding of captopril to angiotensin I-converting enzyme triggers activation of signaling pathways.

  2018cites this paper
• Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

  2018cites this paper
• Translational Relevance and Recent Advances of Animal Models of Abdominal Aortic Aneurysm.

  2017cites this paper
• Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.

  2017cites this paper
• Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

  2017cites this paper
• Prevention of abdominal aortic aneurysm progression by oral administration of green tea polyphenol in a rat model

  2017cites this paper
• Renin-angiotensin system blockade does not attenuate abdominal aortic aneurysm growth, rupture rate, or perioperative mortality after elective repair.

  2017cites this paper
• An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK)

  2016cites this paper
• Association of diabetes mellitus with presence, expansion, and rupture of abdominal aortic aneurysm: "Curiouser and curiouser!" cried ALICE.

  2016cites this paper
• Mast Cell: A Multi-Functional Master Cell

  2016cites this paper
• Pharmacologic Strategies for Preserving Elastic Matrix

  2016cites this paper
• Targeted Nano-Therapeutices for the Reversal of Calcification and ECM Degradation in Abdominal Aortic Aneurysms

  2016cites this paper
• An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK).

  2016cites this paper
• Protective Role of Diabetes Mellitus on Abdominal Aortic Aneurysm Pathogenesis: Myth or Reality?

  2016cites this paper
• Therapeutic Prospect of Adipose-Derived Stromal Cells for the Treatment of Abdominal Aortic Aneurysm

  2015cites this paper
• The Abdominal Aortic Aneurysm and Intraluminal Thrombus: Current Concepts of Development and Treatment

  2015cites this paper
• THE ROLE OF APOB-CONTAINING LIPOPROTEINS IN ABDOMINAL AORTIC ANEURYSM

  2015cites this paper
• Emerging Pharmacological Treatments to Prevent Abdominal Aortic Aneurysm Growth and Rupture.

  2015cites this paper
• Drug Therapy for Small Abdominal Aortic Aneurysm

  2015cites this paper
• Clonal Expansion of T Cells in Abdominal Aortic Aneurysm: A Role for Doxycycline as Drug of Choice?

  2015cites this paper
• Heat shock protein 90 inhibition by 17-DMAG attenuates abdominal aortic aneurysm formation in mice.

  2015cites this paper
• Angiotensin II and Abdominal Aortic Aneurysms: An update.

  2015cites this paper
• An update on the etiology of abdominal aortic aneurysms: implications for future diagnostic testing

  2015cites this paper
• Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Abdominal Aortic Aneurysms: Nation-Wide Cohort Study

  2015cites this paper
• Emerging Pharmacological Treatments to Prevent Abdominal Aortic Aneurysm Growth and Rupture.

  2015cites this paper
• The renin-angiotensin system and its involvement in vascular disease.

  2015cites this paper
• Abdominal aortic aneurysms and diabetes mellitus.

  2015cites this paper
• Statin use and rupture of abdominal aortic aneurysm

  2014cites this paper
• Abdominal Aortic Aneurysms Targeted by Functionalized Polysaccharide Microparticles: a new Tool for SPECT Imaging

  2014cites this paper
• ACE Inhibitors Potently Reduce Vascular Inflammation, Results of an Open Proof-Of-Concept Study in the Abdominal Aortic Aneurysm

  2014cites this paper
• Inhibition of AAA in a rat model by treatment with ACEI perindopril.

  2014cites this paper
• Impaired Glutathione Redox System Paradoxically Suppresses Angiotensin II-Induced Vascular Remodeling

  2014cites this paper
• Angiotensin-converting enzyme I/D polymorphism and aortic aneurysm risk: a meta-analysis.

  2014cites this paper
• Targets for medical therapy to limit abdominal aortic aneurysm progression.

  2014influential citation
• Mise au point de microparticules polysaccharides injectables pour l'imagerie moléculaire de pathologies artérielles

  2014cites this paper
• Factors for sac size change of abdominal aortic aneurysm after endovascular repair.

  2014cites this paper
• Chapter 40 – Aortic Disease

  2013cites this paper
• Angiotensin-II induces phosphorylation of ERK1/2 and promotes aortic adventitial fibroblasts differentiating into myofibroblasts during aortic dissection formation

  2013cites this paper
• Decreases in diameters of treated abdominal aortic aneurysms and reduction in rupture rate.

  2013cites this paper
• Current status of medical treatment for abdominal aortic aneurysm.

  2013cites this paper
• Role of the renin–angiotensin system on abdominal aortic aneurysms

  2013cites this paper
• An investigation into candidate genes for abdominal aortic aneurysms

  2013cites this paper
• А. А. Никоненко МЕДИКАМЕНТОЗНОЕ ЛЕЧЕНИЕ АНЕВРИЗМЫ БРЮШНОЙ АОРТЫ Запорожский государственный медицинский университет Ключевые слова: аневризма брюшного отдела аорты, стабилизирующая терапия, патогенез аневризмы, циклофилин А.

  2013cites this paper
• Efectos de los ligandos de receptores LXR sobre la activación de macrófagos y el desarrollo de aneurismas aórticos abdominales

  2013cites this paper
• Calcium channel blockers enhance sac shrinkage after endovascular aneurysm repair.

  2012cites this paper
• Novel diagnostic and therapeutic targets in Marfan syndrome

  2012cites this paper
• Medical treatment of small abdominal aortic aneurysm.

  2012cites this paper
• Angiotensin-converting enzyme insertion/deletion polymorphism is a risk factor for thoracic aortic aneurysm in patients with bicuspid or tricuspid aortic valves.

  2012cites this paper
• Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms.

  2012cites this paper
• Efficacy and Mechanism of Angiotensin II Receptor Blocker Treatment in Experimental Abdominal Aortic Aneurysms

  2012cites this paper
• Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome

  2012cites this paper
• Imidapril inhibits cerebral aneurysm formation in an angiotensin-converting enzyme-independent and matrix metalloproteinase-9-dependent manner.

  2012cites this paper
• Effects of vascular photodynamic therapy in a newly adapted experimental rat aortic aneurysm model.

  2012cites this paper
• Long-term incidence of myocardial infarct, stroke, and mortality in patients operated on for abdominal aortic aneurysms.

  2012cites this paper
• Can pharmacologic agents slow abdominal aortic aneurysm growth?

  2012cites this paper
• Recent Advances in Pharmacotherapy Development for Abdominal Aortic Aneurysm

  2012cites this paper
• Angiotensin-converting enzyme I/D polymorphism and the risk of thoracic aortic dissection in Chinese Han population

  2012cites this paper
• ROLE OF CYCLOOXYGENASE-2 IN ABDOMINAL AORTIC ANEURYSMS IN MICE

  2012cites this paper
• Aktywność metaloproteinaz w ścianie tętniaka aorty brzusznej

  2012cites this paper
• ANDROGEN INCREASES ANGIOTENSIN RECEPTOR TYPE 1A ON SMOOTH MUSCLE CELLS TO PROMOTE ANGIOTENSIN II-INDUCED ABDOMINAL AORTIC ANEURYSMS

  2011cites this paper
• Important Players in the Orchestrated Pathogenesis of Abdominal Aortic Aneurysms

  2011cites this paper
• Statin Therapy Reduces Growth of Abdominal Aortic Aneurysms

  2011cites this paper
• Current status of medical management for abdominal aortic aneurysm.

  2011cites this paper
• Hepatocyte growth factor promotes an anti-inflammatory cytokine profile in human abdominal aortic aneurysm tissue.

  2011cites this paper
• Mast cells: important players in the orchestrated pathogenesis of abdominal aortic aneurysms.

  2011cites this paper
• Nichtoperative Therapie des abdominalen Aortenaneurysmas: eine Illusion?

  2011cites this paper
• Downregulation of remodelling enzymatic activity induced by an angiotensin-converting enzyme inhibitor (perindopril) reduces the degeneration of experimental abdominal aortic aneurysms in a rat model.

  2011cites this paper
• Actual Pharmacological Treatment to Reduce Growth of Small Abdominal Aneurysm

  2011cites this paper